← Back to Clinical Trials
Recruiting NCT07057518

NCT07057518 The Effect of Emotional Freedom Technique on Psychological Health and Well-being in People With Type 2 Diabetes.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07057518
Status Recruiting
Phase
Sponsor Uşak University
Condition Type 2 Diabetes
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-05-06
Primary Completion 2025-07

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
emotional freedom technique

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-05-06 with a primary completion date of 2025-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Type 2 diabetes is a major meatbolic condition. People living with Type 2 diabetes come across a wide range of health issues, including psychological health. Specifically, diabetes distress are in high levels among them. Diabetes distress is associated with psychological states such as anxiety, lower levels of self-care, and higher hemoglobin A1c (HbA1c) levels. The Emotional Freedom Technique consists of cognitive and somatic components and is used to heal an individual's negative emotions and manage associated emotional and physical disorders. The basic principle of this technique is to regulate the flow of energy by stimulating the meridian system and to relax the individual while focusing on the emotional reactions that lead to disability. Although the prevalence of psychological problems associated with T2DM and diabetes is increasing, there are not enough studies showing the effect of Emotional Freedom Technique on the psychological well-being of T2DM individuals.

Eligibility Criteria

Inclusion Criteria: * being over 18 years of age, * having type 2 diabetes, * no psychiatric diagnosis * agreeing to participate in the study. Exclusion Criteria: * be under 18 years of age, * have type 1 diabetes or gestational diabetes, * attend any course on coping with diabetes distress and anxiety, * have advanced mental health problems.

Contact & Investigator

Central Contact

Aycan ÇELİK ESMER, PhD

✉ aycan.esmer@usak.edu.tr

📞 +922122223085

Frequently Asked Questions

Who can join the NCT07057518 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07057518 currently recruiting?

Yes, NCT07057518 is actively recruiting participants. Contact the research team at aycan.esmer@usak.edu.tr for enrollment information.

Where is the NCT07057518 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07057518 clinical trial?

NCT07057518 is sponsored by Uşak University. The trial plans to enroll 80 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology